Literature DB >> 8150232

Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.

L A Velloso1, O Winqvist, J Gustafsson, O Kämpe, F A Karlsson.   

Abstract

Beta-cell function and islet cell antibodies were studied in six patients with autoimmune polyendocrine syndrome type I. All suffered from mucocutaneous candidiasis, five had adrenocortical insufficiency and three hypoparathyroidism. All sera contained high titres of antibodies staining islets of Langerhans. Reactivity against glutamate decarboxylase, predominantly the 65 kDa isoform, was detected by immunoprecipitations and Western blots in five of the six sera, and all six sera immunoprecipitated a 51 kDa antigen from [35S]-methionine labelled rat islet cell lysates. No reactivity against this latter antigen was found in sera of patients with Type 1 (insulin-dependent) diabetes mellitus (n = 9), Graves' disease (n = 5), autoimmune gastritis (n = 4), idiopathic Addison's disease (n = 7), or stiff-man syndrome (n = 2). The 51 kDa antigen was also detected by Western blots using homogenates of rat islets and autoimmune polyendocrine syndrome type I patient sera, whereas no such reactivity was found with homogenates of testes, adrenals, small intestine, spleen, exocrine pancreas or brain. Moreover, the 51 kDa antigen was present in the rat insulinoma cell line RINm 5F but not in the SV-40 transformed, monkey kidney cell line COS, when examined by immunoprecipitations of [35S]-methionine labelled cell lysates and by Western blots. None of the patients with autoimmune polyendocrine syndrome type I had symptoms of diabetes and their insulin responses to glucose challenge were normal. The data illustrate that patients with autoimmune polyendocrine syndrome type I present an autoimmune response against islets of Langerhans, which is apparently different from that associated with classic Type 1 diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150232     DOI: 10.1007/bf00428779

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

Review 1.  Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis?

Authors:  J P Banga; A M McGregor
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

2.  High-glucose stimulation of 64,000-Mr islet cell autoantigen expression.

Authors:  O Kämpe; A Andersson; E Björk; A Hallberg; F A Karlsson
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

3.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

4.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

5.  The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism.

Authors:  R M Blizzard; D Chee; W Davis
Journal:  Clin Exp Immunol       Date:  1966-04       Impact factor: 4.330

6.  Diabetes mellitus: the incidence of circulating antibodies against thyroid, gastric, and adrenal tissue.

Authors:  D E Goldstein; A Drash; J Gibbs; R M Blizzard
Journal:  J Pediatr       Date:  1970-08       Impact factor: 4.406

7.  Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins.

Authors:  M R Christie; R Y Tun; S S Lo; D Cassidy; T J Brown; J Hollands; M Shattock; G F Bottazzo; R D Leslie
Journal:  Diabetes       Date:  1992-07       Impact factor: 9.461

8.  Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase.

Authors:  L D Fricker; S H Snyder
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

9.  Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease.

Authors:  O Winqvist; J Gustafsson; F Rorsman; F A Karlsson; O Kämpe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR.

Authors:  P Ahonen; S Koskimies; M L Lokki; A Tiilikainen; J Perheentupa
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

View more
  9 in total

1.  beta3-Adrenergic-dependent and -independent mechanisms participate in cold-induced modulation of insulin signal transduction in brown adipose tissue of rats.

Authors:  Alessandra L Gasparetti; Fernanda Alvarez-Rojas; Eliana P de Araujo; Aparecida E Hirata; Mário J A Saad; Lício A Velloso
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

2.  AIRE expression controls the peripheral selection of autoreactive B cells.

Authors:  Joel Sng; Burcu Ayoglu; Jeff W Chen; Jean-Nicolas Schickel; Elise M N Ferre; Salomé Glauzy; Neil Romberg; Manfred Hoenig; Charlotte Cunningham-Rundles; Paul J Utz; Michail S Lionakis; Eric Meffre
Journal:  Sci Immunol       Date:  2019-04-12

Review 3.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

4.  Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.

Authors:  C Davenport; P M Radford; T A Al-Bukhari; M Lai; G F Bottazzo; I Todd
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 5.  Autoimmune regulator (AIRE) gene on chromosome 21: implications for autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) any more common manifestations of endocrine autoimmunity.

Authors:  G Meyer; K Badenhoop
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

6.  Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen.

Authors:  F Rorsman; E S Husebye; O Winqvist; E Björk; F A Karlsson; O Kämpe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

7.  T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.

Authors:  M Costa; A Saiz; R Casamitjana; M Fernández Castañer; A Sanmartí; F Graus; D Jaraquemada
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

8.  Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system.

Authors:  A S Bøe; G Bredholt; P M Knappskog; A Storstein; C A Vedeler; E S Husebye
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

Review 9.  Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" Disease.

Authors:  Alessandra Fierabracci
Journal:  Int J Mol Sci       Date:  2016-07-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.